References

References: l. Siegel, M, Sollecito T, and Stoopler ET. American Academy of Oral Medicine: Clinician’s Guide to Treatment of Ccmmon Oral Conditions. 8th ed. 2017. 2. Neville B, et al. Oral and Maxillofacial Pathology. 4th ed. 2016: Elsevier. 3. Woo SB, Oral Pathology: A Comprehensive Atlas and Text. 2nd ed. 2017: Elsevier. 4. Brennan M, Fox P. American Academy of Oral Medicine: Clinician’s Guide to Salivary Gland and Chemosensory Disorders. 2nd ed. 2019. 5. Adibi S, et al. American Academy of Oral Medicine: Clinician’s Guide to Diagnosis and Treatment of Chronic Orofacial Pain. 4th ed. 2017. 6. Lombardi A, Ouanounou A, Fungal infections in dentistry: clinical presentations, diagnosis, and treatment alternatives. Oral Surg Oral Med Oral Pathol Oral Radiol 2020;130(5):533-546. 7. Fang J, Huang B, Ding Z. Efficacy of antifungal drugs in the treatment of oral candidiasis: a Bayesian network meta-analysis. J Prosthet Dent 2021;125(2):257-265. 8. Sirois, DA. Oral manifestations of HIV disease. Mt Sinai J Med, 1998;65(5-6):322-32. 9. Schneider SL, Kohen LL. Infectious Disease. 2020, Springer International Publishing, 257-288. 10. Pinto A, Haberland CM, Baker S. Pediatric soft tissue oral lesions. Dent Clin North Am 2014;58(2):437-53. 11. Muzyka BC, Epifanio RN. Update on oral fungal infections. Dent Clin North Am 2013;57(4):561-81. 12. Muzyka BC et al. American Academy of Oral Medicine: Clinician’s guide treatment of patients with HIV and other communicable diseases. 5th ed. 2018. 13. Seymour RA. Effects of medications on the periodontal tissues in health and disease. Periodontol 2000,2006;40:120-9. 14. Seymour RA, Ellis JS, Thomason JM. Risk factors for drug-induced gingival overgrowth. J Clin Periodontol 2000;27(4):217-23. 15. Gonsalves WC, Chi AC, Neville BW. Common oral lesions: part I. Superficial mucosal lesions. Am Fam Physician 2007;75(4):501-7. 16. Balasubramaniam R, Kuperstein AS, Stoopler ET. Update on oral herpes virus infections. Dent Clin North Am 2014;58(2):265-80. 17. Cernik C, Gallina K, Brodell RT. The treatment of herpes simplex infections: an evidence-based review. Arch Intern Med 2008; 168(11):1137-44. 18. Fitzpatrick SG, Hirsch SA, Gordon SC. The malignant transformation of oral lichen planus and oral lichenoid lesions: a systematic review. J Am Dent Assoc 2014;145(1):45-56. 19. Rhodus NL, Kerr AR, Patel K. Oral cancer: leukoplakia, premalig�nancy, and squamous cell carcinoma. Dent Clin North Am 2014; 58(2):315-40. 20. Newman M, et al. Newman and Carranza’s Clinical Periodontol�ogy. 13th ed. 2019: Elsevier. 21. Müller S. Oral lichenoid lesions: distinguishing the benign from the deadly. Mod Pathol 2017;30(s1):S54-s67. 22. Little J, Miller C, Rhodus N. Little and Falace’s Dental Management of the Medically Compromised Patient. 9th ed. 2018: Elsevier. 23. Casiglia J, Jacobsen P. American Academy of Oral Medicine: Clini�cian’s Guide to Pharmacology in Dental Medicine. 2nd ed. 2009. 24. Buglione M, et al. Oral toxicity management in head and neck can�cer patients treated with chemotherapy and radiation: xerostomia and tris�mus (Part 2). Literature review and consensus statement. Crit Rev Oncol He�matol 2016:102:47-54. 25. Bensadoun RJ, et al. A systematic review of trismus induced by can�cer therapies in head and neck cancer patients. Support Care Cancer 2010;18(8):1033-8. 26. Hupp WC, Migliorati C, Brennan, M. American Academy of Oral Medicine: The Dentist’s Role in the Management of the Cancer Patient. 1st ed. 2011. 27. Fischer DJ, Klasser GD, Epstein JB. Cancer and orofacial pain. Oral Maxillofac Surg Clin North Am 2008;20(2):287-301, vii. 28. Thariat J, et al. Conservation of salivary function and new external head and neck radiation techniques. Eur Ann Otorhinolaryngol Head Neck Dis 2010;127(6):197-203. 29. Lozada-Nur F, et al., Dysgeusia in COVID-19: possible mechanisms and implications. Oral Surg Oral Med Oral Pathol Oral Radiol 2020;130(3):344-346.

i. Little J, Miller C, Rhodus N. Little and Falace’s Dental management of the Medically Compromised Patient, 9th ed., 2018; Elsevier. ii. Adibi S, et al. American Academy of Oral Medicine: Clinician’s Guide to Diagnosis and Treatment of Chronic Orofacial Pain, 4th ed., 2027. iii. Siegel M, Sollecito T, Stoopler ET. American Academy of Oral Medicine: Clinician’s Guide to Treatment of Common Oral Conditions, 8th ed., 2017. iv. Patton LL, et al. Management of burning mouth syndrome: system�atic review and management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103 Suppl:S39.e1-13. v. Brennan M, Fox P. American Academy of Oral Medicine: Clinician’s Guide to Salivary Gland and Chemosensory Disorders, 2nd ed., 2019. vi. Neville B, et al. Oral and Maxillofacial Pathology, 4th ed., 2016; Elsevier. vii. Martin WJ, Forouzanfar T. The efficacy of anticonvulsants on orofacial pain: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;111(5):627-33. viii. Rodriguez-de Rivera-Campillo E, and Lopez-Lopez J. Evaluation of the response to treatment and clinical evolution in patients with burning mouth syndrome. Med Oral Pathol Oral Cir Bucal 2013;18(3):e403-10. ix. Kim MG, Choi JH, Kho HS. Long-term prognosis of burning mouth syndrome following treatment. Int J Oral Maxillofac Surg 2022;51(12):1538-1544. x. Lombardi A, Ouanounou A. Fungal infections in dentistry: clinical presentations, diagnosis, and treatment alternatives. Oral Surg Oral Med Oral Pathol Oral Radiol 2020;130(5):533-546. xi. Fang J, Huang B, Ding Z. Efficacy of antifungal drugs in the treatment of oral candidiasis: A Bayesian network meta-analysis. J Prosthet Dent 2021;125(2):257. xii. Sirois DA, Oral manifestations of HIV disease. Mt Sinai J Med 1998;65(5-6):322-32. xiii. Schneider SL, Kohen LL. Infectious Disease. 2020, Springer International publishing, 257-288. xiv. Pinto A, Haberland CM, Baker S. Pediatric soft tissue oral lesions. Dent Clin North Am 2014;58(2):437-53. xv. Muzyka BC, Epifanio RN. Update on oral fungal infections. Dent Clin North Am 2013;57(4):561-81. xvi. Woo S-B, Oral Pathology: A Comprehensive Atlas and Text, 2nd ed., 2017: Elsevier. xvii. Muzyka BC, et al. American Academy of Oral Medicine: Clinician’s Guide Treatment of Patients with HIV and Other Communicable Diseases, 5th ed., 2018. xviii. Seymour RA. Effects of medications on the periodontal tissues in health and disease. Periodontol 2000, 2006;40:120-9. xix. Seymour RA, Ellis JS, Thomason JM. Risk factors for drug-induced gingival overgrowth. J Clin Periodontol 2000;27(4):217-23. xx. Gonsalves WC, Chi AC, Neville BW. Common oral lesions: Part I. Superficial mucosal lesions. Am Fam Physician 2007;75(4):501-7. xxi. Balasubramaniam R, Kuperstein AS, Stoopler ET. Update on oral herpes virus infections. Dent Clin North Am 2014;58(2):265-80. xii. Cernik C, Gallina K, Brodell RT. The treatment of herpes simplex infections: an evidence-based review. Arch Intern Med 2008;168(11):1137-44. xxiii. Newman M, et al. Newman and Carranza’s Clinical Periodon�tology, 13th ed., 2019, Elsevier. xxiv. Rhodus NL, Kerr AR, Patel K. Oral cancer: leukoplakia, premalignancy, and squamous cell carcinoma. Dent Clin North Am 2014;58(2):315-40. xxv. Fitzpatrick SG, Hirsch SA, Gordon SC. The malignant transforma�tion of oral lichen planus and oral lichenoid lesions: a systematic review. J Am Dent Assoc 2014;145(1):45-56. xxvi. Müller S. Oral lichenoid lesions: distinguishing the benign from the deadly. Mod Pathol 2017;30(s1):S54-s67. xxvii. Casiglia J, Jacobsen P. American Academy of Oral Medicine: Clinician’s Guide to Pharmacology in Dental Medicine, 2nd ed., 2009. xxviii. Buglione M, et al. Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: xerostomia and trismus (part 2). Literature review and consensus statement. Crit Rev Oncol Hematol 2016;102:47-54. xxix. Bensadoun RJ, et al. A systematic review of trismus induced by cancer therapies in head and neck cancer patients. Support Care Cancer 2010;18(8):1033-8. xxx. Hupp W, Migliorati C, Brennan M. American Academy of Oral Medicine: The Dentist’s Role in the Management of the Cancer Patient, 1st ed., 2011. xxxi. Fischer DJ, Klasser GD, Epstein JB. Cancer and orofacial pain. Oral Maxillofac Surg Clin North Am 2008;20(2):287-301,vii. xxxii. Thariat J, et al. Conservation of salivary function and new external head and neck radiation techniques. Eur Ann Otorhinolaryngol Head Neck Dis 2010;127(6):197-203. xxxiii. Lozada-Nur F, et al. Dysgeusia in COVID-19: possible mecha�nisms and implications. Oral Surg Oral Med Oral Pathol Oral Radiol 2020;130(3):344-346.